Related Experiment Video
Updated: Jul 28, 2026

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat (VNTR) - Fragment Length Analysis (FLA)
Published on: July 15, 2011
Rifampicin-resistant strains of Mycobacterium leprae may have reduced virulence
R D McDermott-Lancaster1, G R Hilson
1Department of Medical Microbiology, St. George's Hospital Medical School, London.
Abstract:
A strain of Mycobacterium leprae resistant to rifampicin (RMP) failed to infect normal mice when injected into the foot pads (FP) at a dose of 10 or 100 bacilli/FP, although it could be maintained by serial passage in mice by the use of inocula of 10(4) bacilli/FP; normal mice can be infected by RMP-sensitive M. leprae at a dose of 10 bacilli/FP. By contrast, nude (athymic) mice could be infected with an inoculum of 10 bacilli/FP of the RMP-resistant strain. It is suggested that the strain concerned possessed reduced virulence for normal mice, and the implications of this for the probability of occurrence of human disease caused by RMP-resistant strains of M. leprae are discussed.
Insights
Rifampicin-resistant Mycobacterium leprae showed reduced infectivity in normal mice but could infect nude mice. This suggests decreased virulence, impacting the risk of human disease from resistant leprosy strains.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Leprosy, caused by Mycobacterium leprae, is a curable infectious disease.
- Rifampicin (RMP) is a key drug in multidrug therapy for leprosy.
- Emergence of drug-resistant M. leprae strains poses a significant public health challenge.
Purpose of the Study:
- To investigate the infectivity and virulence of a rifampicin-resistant (RMP-resistant) Mycobacterium leprae strain in mouse models.
- To compare the infectivity of RMP-resistant M. leprae with RMP-sensitive M. leprae in normal and immunocompromised mice.
Main Methods:
- Infection studies using RMP-resistant and RMP-sensitive M. leprae strains in the foot pads (FP) of normal and nude (athymic) mice.
- Varying inocula doses (10, 100, or 10^4 bacilli/FP) were used to assess infectivity.
- Serial passage in mice was employed to maintain the RMP-resistant strain.
Main Results:
- RMP-resistant M. leprae failed to infect normal mice at doses of 10 or 100 bacilli/FP.
- Normal mice were infectable with RMP-sensitive M. leprae at 10 bacilli/FP.
- Nude (athymic) mice were successfully infected with RMP-resistant M. leprae at an inoculum of 10 bacilli/FP.
Conclusions:
- The RMP-resistant M. leprae strain exhibited reduced virulence in normal mice.
- The findings suggest that RMP-resistant M. leprae may have a lower probability of causing disease in immunocompetent individuals.
- Further research is needed to understand the full implications for human leprosy caused by drug-resistant strains.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Microbial Interactions: Parasitism
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Antiprotozoal Agents

